Treatment of Cystitis
For uncomplicated cystitis, first-line treatment options include fosfomycin trometamol (3g single dose), nitrofurantoin (100mg twice daily for 5 days), or pivmecillinam (400mg three times daily for 3-5 days), with the choice guided by local resistance patterns and patient factors. 1
Diagnosis and Classification
- Uncomplicated cystitis is defined as acute, sporadic, or recurrent cystitis in non-pregnant women without anatomic or functional urinary tract abnormalities or comorbidities 1
- Diagnosis can be made with high probability based on lower urinary tract symptoms (dysuria, frequency, urgency) and absence of vaginal discharge 1
- In patients with typical symptoms, urine analysis provides minimal increase in diagnostic accuracy, but dipstick testing can help when diagnosis is unclear 1
- Urine culture is recommended for:
- Suspected pyelonephritis
- Symptoms that don't resolve or recur within 4 weeks after treatment
- Women with atypical symptoms
- Pregnant women 1
Treatment Recommendations for Uncomplicated Cystitis
First-line Treatment Options for Women:
Fosfomycin trometamol: 3g single dose 1
- Advantages: Minimal resistance, low collateral damage, single-dose convenience
- Limitation: May have slightly inferior efficacy compared to other regimens
Nitrofurantoin: Multiple formulation options 1
- Macrocrystals: 50-100mg four times daily for 5 days
- Monohydrate/macrocrystals: 100mg twice daily for 5 days
- Macrocrystals prolonged release: 100mg twice daily for 5 days
Pivmecillinam: 400mg three times daily for 3-5 days (availability limited to some European countries) 1
Alternative Options (when first-line agents cannot be used):
Cephalosporins (e.g., cefadroxil): 500mg twice daily for 3 days (if local E. coli resistance <20%) 1
Trimethoprim: 200mg twice daily for 5 days (avoid in first trimester of pregnancy) 1
Trimethoprim-sulfamethoxazole: 160/800mg twice daily for 3 days (avoid in last trimester of pregnancy, use only if local resistance <20%) 1, 2
Fluoroquinolones: Highly effective but should be reserved for more serious infections due to concerns about collateral damage and resistance 1
Treatment for Men:
- Trimethoprim-sulfamethoxazole: 160/800mg twice daily for 7 days 1
- Fluoroquinolones can be prescribed according to local susceptibility testing 1
Special Considerations
For women with mild to moderate symptoms, symptomatic therapy (e.g., ibuprofen) may be considered as an alternative to antimicrobial treatment in consultation with individual patients 1
The choice of antimicrobial should be guided by:
- Local resistance patterns of uropathogens
- Efficacy demonstrated in clinical studies
- Tolerability and adverse reactions
- Ecological effects (impact on normal flora)
- Cost and availability 1
For symptoms that don't resolve by the end of treatment or recur within 2 weeks:
- Perform urine culture and antimicrobial susceptibility testing
- Assume the infecting organism is not susceptible to the original agent
- Consider retreatment with a 7-day regimen using a different agent 1
Routine post-treatment urinalysis or cultures are not indicated for asymptomatic patients 1
Management of Recurrent UTIs
- Defined as ≥3 UTIs per year or ≥2 UTIs in the last 6 months 1
- Diagnose via urine culture (strong recommendation) 1
- Extensive workup (cystoscopy, abdominal ultrasound) not recommended for women <40 years without risk factors 1
- Preventive measures include:
Common Pitfalls and Caveats
- Using fluoroquinolones as first-line therapy when other options are available (increases risk of resistance) 1
- Using amoxicillin or ampicillin empirically (high resistance rates worldwide) 1
- Treating asymptomatic bacteriuria outside of specific indications (pregnancy, before urological procedures breaching mucosa) 1
- Failing to obtain cultures in patients with recurrent or persistent symptoms 1
- Not adjusting therapy based on local resistance patterns, particularly for trimethoprim-sulfamethoxazole 1
- Prescribing longer courses of antibiotics than necessary (3-5 days is typically sufficient for uncomplicated cystitis) 1, 3